Light Bulb Stimuli to Reduce Chronic Pain

NCT ID
NCT07825792
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
University of North Carolina, Chapel Hill
Conditions
Fibromyalgia, Musculoskeletal Pain

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity Using Light Bulbs: A Pilot Randomized Crossover Trial

Enrollment: 40 participants (Estimated).

What is being studied

  • Device: Equal-Energy White Light
  • Device: S-Cone Stimulating Chromatic Light

Who may be eligible

Ages
18 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Adults ≥ 18 years of age. * Individuals who have been diagnosed with fibromyalgia or suffer from chronic widespread pain and fatigue. * An average pain severity ≥4 on the 0-10 NRS over the month prior to enrollment. * Pain symptoms present for 3 months or longer. * Pain must be present in 4 out of 5 body regions. * A score of ≥7 on the Widespread pain index (WPI) and ≥5 on the symptom severity scale (SSS), or 4-6 on the WPI and ≥9 on the SSS in the 2016 Fibromyalgia Questionnaire. * Willingness to adjust light levels in home environment so that the illumination (measured in lux) provided by the light bulbs is twice the ambient room illumination (also measured in lux). * Willingness to use study lightbulbs for 2 consecutive hours a day for 7 consecutive days according to study specifications for both conditions (total of 14 days using lightbulbs) * Alert and oriented, and able to provide informed consent * Ability to read and speak English to complete validated questionnaires. Exclusion Criteria: * Vision disorders or conditions resulting in severe vision impairment or blindness * Individuals with self-report of color blindness, uveitis or cataracts. * Prisoner Status * Pregnancy * History of photosensitivity or sensitivity to scintillating (mildly flickering) light. * History of seizure disorder. * Individuals living in households with people who have a history of seizure disorders. * Analgesic treatment plan changes anticipated in the next 3 months (surgery, analgesic medication changes, injections, pain procedures, etc.). * Other history or condition that would, in the investigator's judgment, indicate that the individual would highly likely be non-compliant with the study or unsuitable for the study

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • North Carolina, United States: 1

Sample of listed locations

  • University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, 27514, United States — Site recruitment status not specified in the registry data

Study details

Start date
September 21, 2026
Primary completion date
January 1, 2028
Completion date
January 1, 2028
First posted
September 17, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07825792
Registry last updated
September 17, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07825792 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Chronic Pain studies | Clinical trial FAQ